window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : March 11, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Pulmonary Hypertension

  • Cardiovascular diseases,Clinical Trials,Rare Diseases

    Rare Disease Day 2026: Cereno Scientific advances disease-modifying therapies in PAH

    As Rare Disease Day 2026 shines a spotlight on patients [...]

    February 27, 2026
  • Clinical Development,Clinical Trials,Rare Diseases,Respiratory

    Cereno Scientific broadens CS014 development focus to pulmonary hypertension linked to interstitial lung disease

    Cereno Scientific has broadened the clinical development focus of its [...]

    February 5, 2026
  • Chronic diseases,Digital Health,Medical devices,Patient Centricity,Pharmaceuticals and therapeutics,Technology and platforms

    electronRx to launch app for remote respiratory disease management

    electronRx will launch its pDx app at the HLTH 2025 [...]

    October 2, 2025
  • Clinical Development,Clinical Trials,Drug Development

    Corteria advances CRF2 agonist programs in heart failure and obesity

    Corteria Pharmaceuticals has launched a Phase 2 trial of its [...]

    July 22, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  •
    ViiV Healthcare reports 12-month data showing lotivibart maintains viral suppression in ultra long-acting HIV regimen
    Categories: Clinical Development, Infectious Diseases, Patient Centricity, Precision medicine
  • SPT Labtech and Illumina to develop automated platform for decentralised oncology genomics
    Categories: Diagnostics, Oncology, Partnerships & Funding
  • Young adults in US, UK and Australia hit hardest by global mental health decline
    Categories: Clinical studies, Digital Health, Global health, Mental health, Neurosciences
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top